Tell FDA: Preserve Access to IV Glutathione

The California State Board of Pharmacy has proposed regulatory language that would block patient access to IV glutathione, as well as numerous other medications. This serious threat to a crucial medication must be opposed immediately. We are also concerned that California’s actions regarding compounding could give the FDA similar ideas as the agency develops its own policies regarding compounded supplements.

Write to Congress and the FDA, urging them to preserve patient access to compounded glutathione IVs!


  • Your Senators
  • Your Representative
  • Food and Drug Administration


*Required fields


Preserve Access to IV Glutathione

Dear [Decision Maker],

[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]